IE54167B1 - Process for promoting growth and feed efficiency of food producing mammals - Google Patents
Process for promoting growth and feed efficiency of food producing mammalsInfo
- Publication number
- IE54167B1 IE54167B1 IE1512/82A IE151282A IE54167B1 IE 54167 B1 IE54167 B1 IE 54167B1 IE 1512/82 A IE1512/82 A IE 1512/82A IE 151282 A IE151282 A IE 151282A IE 54167 B1 IE54167 B1 IE 54167B1
- Authority
- IE
- Ireland
- Prior art keywords
- lysocellin
- feed
- animal
- growth
- manganese
- Prior art date
Links
- 230000012010 growth Effects 0.000 title claims abstract description 18
- 235000013305 food Nutrition 0.000 title claims abstract description 12
- 230000001737 promoting effect Effects 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 26
- 241000124008 Mammalia Species 0.000 title abstract description 7
- KTQFYFLZDLTLAH-UHFFFAOYSA-N Lysocellin Natural products CCC(O)C1(CC)CC(C)C(O)(O1)C2(C)CC(C)C(O2)C(CC)C(=O)C(C)C(O)C(C)C3OC(O)(CC(=O)O)C(C)CC3C KTQFYFLZDLTLAH-UHFFFAOYSA-N 0.000 claims abstract description 104
- KTQFYFLZDLTLAH-DESDHLEASA-N lysocellin Chemical compound O1[C@]([C@@H](O)CC)(CC)C[C@@H](C)[C@]1(O)[C@@]1(C)O[C@H]([C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CC(O)=O)O2)C)[C@@H](C)C1 KTQFYFLZDLTLAH-DESDHLEASA-N 0.000 claims abstract description 103
- 241000282849 Ruminantia Species 0.000 claims abstract description 13
- 239000010949 copper Substances 0.000 claims abstract description 12
- 229910052802 copper Inorganic materials 0.000 claims abstract description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 229910052751 metal Inorganic materials 0.000 claims abstract 5
- 239000002184 metal Substances 0.000 claims abstract 5
- 241001465754 Metazoa Species 0.000 claims description 38
- 239000000463 material Substances 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 18
- 239000011572 manganese Substances 0.000 claims description 17
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 15
- 239000011734 sodium Substances 0.000 claims description 15
- 229910052708 sodium Inorganic materials 0.000 claims description 15
- 229910052748 manganese Inorganic materials 0.000 claims description 14
- 210000004767 rumen Anatomy 0.000 claims description 14
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 239000003674 animal food additive Substances 0.000 claims description 4
- 230000001965 increasing effect Effects 0.000 claims description 4
- 159000000003 magnesium salts Chemical class 0.000 claims description 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 235000019730 animal feed additive Nutrition 0.000 claims 4
- HPDFFVBPXCTEDN-UHFFFAOYSA-N copper manganese Chemical compound [Mn].[Cu] HPDFFVBPXCTEDN-UHFFFAOYSA-N 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 abstract description 6
- 150000002696 manganese Chemical class 0.000 abstract description 4
- KSHPUQQHKKJVIO-UHFFFAOYSA-N [Na].[Zn] Chemical compound [Na].[Zn] KSHPUQQHKKJVIO-UHFFFAOYSA-N 0.000 abstract 1
- 150000004696 coordination complex Chemical class 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 229920000570 polyether Polymers 0.000 description 10
- 239000004721 Polyphenylene oxide Substances 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 241000283903 Ovis aries Species 0.000 description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- DIKYHBWGIUNGIW-UHFFFAOYSA-N 2-[2,4-dihydroxy-6-[1-[2-[5-[5-(6-hydroxy-4-methoxy-3,5,6-trimethyloxan-2-yl)oxolan-2-yl]-5-methyloxolan-2-yl]-7-methoxy-2,6-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]ethyl]-5-(5-methoxy-6-methyloxan-2-yl)oxy-3,5-dimethyloxan-2-yl]propanoic acid Chemical compound O1C(C)C(OC)CCC1OC1(C)C(C(C)C2OC3(OC(C)(CC3)C3OC(C)(CC3)C3OC(CC3)C3C(C(OC)C(C)C(C)(O)O3)C)C(C)C(OC)C2)OC(O)(C(C)C(O)=O)C(C)C1O DIKYHBWGIUNGIW-UHFFFAOYSA-N 0.000 description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
- 229930191564 Monensin Natural products 0.000 description 6
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229960005358 monensin Drugs 0.000 description 6
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 150000001879 copper Chemical class 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- -1 e.g. Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NZHCPUBOSWFGNA-MKODDJJXSA-N 3-chloro-2-[(2s,4r,5s,6s,8r)-8-[(1r,2r,3r,7r,9s,10s,12r,15r)-3-[(2r,4r)-5-ethoxycarbonyl-4-hydroxyoxolan-2-yl]-15-hydroxy-2-methoxy-1,3,10,12-tetramethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-5-hydroxy-4,6-dimethyl-7-oxononan-2-yl]-6-hy Chemical compound C1[C@@H](O)C(C(=O)OCC)O[C@H]1[C@]1(C)[C@H](OC)[C@@H](C)C2([C@@H](C=C[C@@]3([C@@H](C[C@H](C)[C@@H]([C@@H](C)C(=O)[C@@H](C)[C@@H](O)[C@H](C)C[C@H](C)C=4C(=C(O)C(C)=CC=4Cl)C(O)=O)O3)C)O2)O)O1 NZHCPUBOSWFGNA-MKODDJJXSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 229930182504 Lasalocid Natural products 0.000 description 2
- 235000019738 Limestone Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 241000186990 Streptomyces cacaoi Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003224 coccidiostatic agent Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940076286 cupric acetate Drugs 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- DANUORFCFTYTSZ-UHFFFAOYSA-N epinigericin Natural products O1C2(C(CC(C)(O2)C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)C)C(C)C(OC)CC1CC1CCC(C)C(C(C)C(O)=O)O1 DANUORFCFTYTSZ-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- BBMULGJBVDDDNI-OWKLGTHSSA-N lasalocid Chemical compound C([C@@H]1[C@@]2(CC)O[C@@H]([C@H](C2)C)[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC=2C(=C(O)C(C)=CC=2)C(O)=O)C[C@](O)(CC)[C@H](C)O1 BBMULGJBVDDDNI-OWKLGTHSSA-N 0.000 description 2
- 229960000320 lasalocid Drugs 0.000 description 2
- 239000006028 limestone Substances 0.000 description 2
- MSBWDNNCBOLXGS-UHFFFAOYSA-L manganese(2+);diacetate;hydrate Chemical compound O.[Mn+2].CC([O-])=O.CC([O-])=O MSBWDNNCBOLXGS-UHFFFAOYSA-L 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- DANUORFCFTYTSZ-BIBFWWMMSA-N nigericin Chemical compound C([C@@H]1C[C@H]([C@H]([C@]2([C@@H](C[C@](C)(O2)C2O[C@@](C)(CC2)C2[C@H](CC(O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C)O1)C)OC)[C@H]1CC[C@H](C)C([C@@H](C)C(O)=O)O1 DANUORFCFTYTSZ-BIBFWWMMSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical group CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000002460 polyether antibiotic agent Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 244000202285 Acrocomia mexicana Species 0.000 description 1
- 235000003625 Acrocomia mexicana Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 208000008034 Contagious Ecthyma Diseases 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241001057636 Dracaena deremensis Species 0.000 description 1
- 241000223932 Eimeria tenella Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- VHKXXVVRRDYCIK-UHFFFAOYSA-N Narasin Natural products CC1CC(C)C(C(CC)C(O)=O)OC1C(C)C(O)C(C)C(=O)C(CC)C1C(C)CC(C)C2(C=CC(O)C3(OC(C)(CC3)C3OC(C)C(O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-UHFFFAOYSA-N 0.000 description 1
- VHKXXVVRRDYCIK-CWCPJSEDSA-N Narasin Chemical compound C[C@H]1C[C@H](C)[C@H]([C@@H](CC)C(O)=O)O[C@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-CWCPJSEDSA-N 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 206010031071 Orf Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 description 1
- 239000004189 Salinomycin Substances 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 241000970926 Streptomyces longwoodensis Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- XSBSGLXIQBCTKN-SARHNJKISA-N X-206 Chemical compound C1C[C@](O)(C)[C@H](CC)O[C@H]1[C@@]1(C)O[C@@](O)([C@@]2(C)O[C@@H](CC2)[C@@H](O)[C@@]2(O)[C@@H](C[C@H](C)[C@@H](C[C@]3(O)[C@H](CC[C@@H](O3)[C@@H](C)[C@H](O)C[C@@H]3O[C@@H]([C@@H](C)CC3)[C@@H](C)C(O)=O)C)O2)C)[C@H](C)C1 XSBSGLXIQBCTKN-SARHNJKISA-N 0.000 description 1
- XSBSGLXIQBCTKN-UHFFFAOYSA-N X-206 Natural products C1CC(O)(C)C(CC)OC1C1(C)OC(O)(C2(C)OC(CC2)C(O)C2(O)C(CC(C)C(CC3(O)C(CCC(O3)C(C)C(O)CC3OC(C(C)CC3)C(C)C(O)=O)C)O2)C)C(C)C1 XSBSGLXIQBCTKN-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000001165 anti-coccidial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 201000005332 contagious pustular dermatitis Diseases 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 229940075894 denatured ethanol Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 229960001851 narasin Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229960001548 salinomycin Drugs 0.000 description 1
- 235000019378 salinomycin Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- XOIQMTLWECTKJL-BEMBKCOJSA-M sodium;(2s,3r,4s)-4-[(2s,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)CC21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C([O-])=O)O2 XOIQMTLWECTKJL-BEMBKCOJSA-M 0.000 description 1
- DGPIGKCOQYBCJH-UHFFFAOYSA-M sodium;acetic acid;hydroxide Chemical compound O.[Na+].CC([O-])=O DGPIGKCOQYBCJH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
The growth and feed efficiency of food producing domestic mammals (especially ruminants) is improved by administering, a growth- promoting amount of the antibiotic lysocellin or a physiologically acceptable salt or metal complex thereof. Preferred metal complexes or salts of lysocellin are the sodium zinc, copper, and manganese derivatives.
Description
SCIENCE REFERENCE AND
INFORMATION SERVICE
Price 90p
B4167
The present invention relates to an animal growth promoting process which utilizes certain forms of lysocellin as a growth-promoting substance in food-producing mammals and is a patent of addition to Application No. 1368/80.
A fairly comprehensive review of the various classes of polyether antibiotics is set forth in Westley, Adv. Appl. Microbiology 22, 177-223 (1977). Lysocellin falls into Class 2a as defined by Westley. Class 2a comprises divalent polyethers of a linear configuration
416 7 which may contain from about two or about three tetrahydropyran and/or furan structures, up to three totai ring structures and no nitrogen atoms. Table VIII of the Westley publication discloses the effective level of lysocellin as a coccidiostat. Lysocellin at 300 ppm in feed was said to be effective against Eimeria tenella. The reference refers to the use of lysocellin in poultry feed, and the level of lysocellin required to function as a coccidiostat considerably greater than other polyether antibiotics, such as monensin, nigericin, lasalocid and others.
Lysocellin was first reported in the literature by Ebata, et al. The Journal of Antibiotics 28 (2); 118-121, 1975. The physico-chemical properties of lysocellin are described there, including a melting point of about 158-160° C. of the colorless needles of the sodium salt. The antibiotic is said to be produced from a mutant strain of Streptomyces cacaoi var. asoensis designated Streptomyces cacaoi var. asoensis
K-9 Met-, but this strain has apparently not been made available to the public. This reference discloses that lysocellin is active against gram-positive bacteria, antibiotic resistant Staphylococcus aureus, some fungi, but that it is not active against gram25 negative bacteria. There is no disclosure here of any use of lysocellin in meat-producing animals.
The structural formula for lysocellin was set forth by Otake, et al, Agric. Biol. Chem. 42 (10); 18791877, 1978. This reference also reports that lyso30 cellin is effective in treating coccidial infections in poultry, but there is no mention here of any other use of lysocellin in meat-producing animals.
United States Patent 4,033,823, issued July 3,
1977, to Liu, e£ al. discloses the structural formula of lysocellin and a method for making it using Strep54167 tomyces Longwoodensis (ATCC 29251). This patent only describes the use of lysocellin as an antimicrobial.
More recently, lysocellin was compared to a number of other polyether antibiotics for inhibition of ruminal degradation of L-tryptophan (TRP) to 3methylindole (3MI) in vitro. Other polyether antibiotics used for the comparison included desoxysalinomycin,
X-206, nigericin, lasalocid, monensin, narasin and salinomycin. Chloral hydrate was also used. The study was aimed at determining the potential effect of these antibiotics in the treatment of acute bovine pulmonary edema and emphysema (ΑΒΡΕ), or fog fever, which appears to relate to ruminal production of 3MI. Hammond, et al, Journal of Animal Science 51(1):207-214,
1980.
The above study by Hammond, et al, reported that the polyether antibiotics tested were the most effective compounds in reducing in vitro ruminal degradation of TRP to 3MI without significant decrease in
VFA production. However, lysocellin was reported as one of the least effective of the polyether antibiotics tested for this purpose. This publication concludes that further investigations of the effects of monensin on live animals are warranted. No further work with lysocellin was recommended by the authors. It should be noted that monensin did depress tlie VFA production in this test, and that its use as a feed additive is only for improved feed efficiency or utilization. See: United States Patent 3,839,557.
United States Patent 4,129,578, discloses the use of Compound 38,295 (etheromycin) as having anticoccidial, antimicrobial and growth promotant properties. Various cationic salts of etheromycin are disclosed, including copper, zinc, ammonium, calcium, magnesium and lithium salts. However, the microorganism,
Streptomyces hygroscopicus ATCC 31050 used in the above reference has been withdrawn from the culture collection, so the reference is not believed to be enabling as to the growth promoting effects disclosed. In any event, the patent discloses only the use of etheromycin (Antibiotic 38,295 derived from ATCC 31050).
Recently issued United States Patent 4,221,724 Liu et al, discloses the use of polyether antibiotic X14766A as a growth promotant for ruminants. However, the only results reported in this patent were for in vitro volatile fatty acid production. Although such tests may give an indication that a substance will be effective as a growth promotant in ruminants, this is not conclusive, and actual in vivo testing is necessary.
The molecular structure of X-14766A is different from lysocellin. Χ-14766Λ includes a chloride group on a methylbenzoic acid group, there are forty-three carbon atoms in the molecule, and there are four successive heterocyclic polyether rings, whereas lysocellin contains only two successive heterocyclic polyether rings, contains neither chloride groups, nor a methylbenzoic acid group. In addition, lysocellin has a total of only thirty-four carbon atoms in the molecule.
It has now been surprisingly discovered that the various forms of lysocellin act as especially effective growth-promoting and feed efficiency-enhancing agents when administered to food-producing mammals such as ruminants. In ruminants having a developed rumen function, including cattle, sheep and goats, the various forms of lysocellin are believed to promote growth and enhance the efficiency of feed utilization in the animal by lowering the acetate/propionate ratio among the volatile fatty acids (VFA) found in the animal's rumen fluid. The relationship between acetate/propionate ratio in the rumen and feed efficiency in the ruminant animals is explained in greater detail in Raun, U.S. Patent
3,794,732 issued February 26, 1974.
Therefore, the present invention relates to processes for promoting growth and enhancing feeding efficiency in food-producing mammals by administering lysocellin free acid or the sodium, manganese, ccpper or magnesium salts to meat-producing animals, particularly ruminants. Manganese and copper are believed to form salt complexes, and two of the linear polyether molecules wrap around the bivalent cation. For convenience these complexes will be referred to as salts.
In accordance with the present invention, the manganese or copper salts of lysocellin can be formed by adding water-soluble manganese or copper salts to the fermentation broth in which lyso15 cellin has been prepared, and the resulting broth-insoluble manganese or copper complexes of lysocellin can then be recovered from the broth and employed as growth-promoting and feed efficiency enhancing additives, especially in feed for food-producing mammals such as ruminants, swine and poultry.
Lysocellin-containing fermentation broth is prepared in conventional manner by fermenting a nutrientcontaining liquid fermentation medium inoculated with a Streptomyces longwoodens i s (ATCC 29251) which is cap25 able of producing lysocellin. Suitable liquid fermentation media are generally aqueous dispersions containing a nitrogen source and a carbohydrate source. Nitrogen sources for use in the fermentation media herein can include, for example, sugar, molasses, cornsteep liquor and the like. The fermenation media can also contain a variety of optional ingredients, if desired, such as for example, pH adjustment agents, buffers, trace minerals, antifoam agents and filter aids.
The Streptomyces microorganism is grown in an
416 7 aerated, agitated, submerged culture with the pH of the broth adjusted to about neutral, i.e,, from a pli vajur* of about 6.5 to 7.5. Fermentation can gnieraliy be carried out at slightly elevated temperatures,
e.g., between about 25°C and 35°C. Incubation of the broth can be carried out for a period of several days e.g., from about 4 to 6 days or longer if it is economically advantageous to do so.
A particular method for producing the anti10 biotic lysocellin was disclosed by Liu et al in U.S.
Patent 4,033,823, by the cultivation of a strain of Streptomyces longwoodensis which is on unrestricted deposit at the American Type Culture Collection under the designation ATCC 29251. The structure of lysocellin is as follows:
Lysocellin
Suitable methods for preparing the lysocellin antibiotic are set forth in the above-mentioned patent. The char20 acteristics of lysocellin were first set forth in the article by Ebata et al, J. Antibiotics 28:118-121, 1975.
The forms of lysocellin i.e. the free acid, and the sodium, manganese, copper and magnesium salts used in the present invention act as growth-promoting agents in food-producing mammals, e.g., ruminants, swine and poultry.
These forms of lysocellin can be administered to food54167 producing animals, either orally, subcutaneously or parenterally, in amounts sufficient to enhance the growth rate of the animals The amount of the lysocellin material administered to an animal varies, of course, with the species of animal, the desired rate of growth, and the like. The material is frequently administered to ruminants in an amount of about 1 to 200, preferably about 1 to 50 milligrams per head per day.
Preferably, the lysocellin material is adminis]_q tered to food-producing animals in their feed, and can be conveniently added to animal feed in the form of the dried, anti-biotic-containing biomass which is recovered as a feed additive composition from the fermentation broth as hereinbefore described. It may also be ad15 ministered in liquid feeds, and in the animals's drinking water.
A feed composition may be prepared containing the usual nutritionally-balanced quantities of carbohydrates, proteins, vitamins and minerals as diluents
2o together with the lysocellin material. Some of the usual sources of these dietary elements are grains, such as ground grain and grain by-products; animal protein substances, such as those found in fish meal and moat scraps; vegetable proteins, such as soybean oil meal or peanut oil meal; vitaminaceous materials, e.g., mixture of vitamins A and D, riboflavin supplements and other vitamin B complex members; and bone meal and limestone to provide minerals. A type of conventional feed material for use with cattle, for example, includes al30 falfa hay and ground corn cobs, together with supplementary vitaminaceous substances if desired. The lysocellin materials of the present invention can generally be employed in the feed compositions to the extent of from about 15 grams per ton to 200 grams per ton, pref35 erably from about 75 grams per ton to 125 grams per ton.
The lysocellin growth-promoting agents described herein, can also be administered to foodproducing animals subcutaneously or parenterally in combination with a pharmaceutically-acceptable carrier.
For example, the lysocellin materials can be employed in an injection composition, or as an implant under the skin. Administration of the growth-promoting agents herein in this manner can include intra-muscular, intravenous, subcutaneous, and intraperitoneal injections.
When an implant is used, for example, a ball or cylindrical implant inserted under the skin on the ear of an animal, the implant will generally contain from about 1 mg to 100 mg of one of the lysocellin materials.
The various lysocellin materials, their prep15 aration and recovery and the feed and feed additive compositions involved in the present invention as well as their usefulness as growth promoting agents for ruminants are illustrated by the following examples. Such examples include the preparation, recovery and evalua20 tion of the preferred lysocellin material, but are in no way limiting of the present invention to processes involving that particular material.
EXAMPLE 1
Crystalline sodium lysocellin was produced following the fermentation method set forth in Example 1 of U.S. Patent 4,033,823, issued July 5, 1977; which procedure is incorporated herein by reference. The melting point of the resultant crystalline sodium lysocellin isolated from the fermentation broth was 159.6“ (Mettler).
Infra-red spectrum and optical rotation agree with the date for sodium lysocellin published by Otake, et al, op. cit. NMR spectra and elemental analysis of the crystalline material obtained by the above method con5 416 7 firmed that the product was sodium lysocellin.
EXAMPLE II
Sodium lysocellin produced by the method of Example I was used to make the free acid of lysocellin as follows:
3.9 g sodium lysocellin (3(0.006 moles) and 1.4 g zinc acetate hydrate [Zn(Ac) 2·2Η2Ο] (δ (.006 mole) were mixed together in 30 ml denatured ethanol (3A). The sodium lysocellin was first suspended in the ethanol and stirred, and the sodium acetate hydrate was added, and the suspension stirred at room temperature until everythin was dissolved. The pH was then adjusted to a range of 2-4, with 37% HCl. Stirring was continued for 20-30 minutes until precipitation of a birefringent ma15 terial started. Precipitation was continued by adding water dropwise (holding pH at 4) until about 60 ml of water was added. The resulting crystalling precipitate of the free acid of lysocellin was isolated and dried. The resulting free acid of lysocellin comprised bire20 fringent crystals.
The above material was again dissolved in ethanol and recrystallized from ethanol by again adding water dropwise until the free acid of lysocellin precipitated out as birefringent crystals. The melting point of this material was 147.5°C (Mettler), and the analysis (percent by weight) was C, 65.45% U, 9.57%; and 0, 24.90% and showed the molecule to comprise C34I160°10 ^lysocellin, free acid).
EXAMPLE III
The sodium lysocellin made according to the method of Example I was used to make the crystalline manganese salt of lysocellin by the following method:
1.3 g of sodium lysocellin and 0.5 g of manganese acetate hydrate [Mn(Ac)2,21^0] were added to 15 ml of acetone. The reactants were stirred at room temperature until all solids were in solution. Stirring was continued, and 30 ml of water was added dropwise to cause precipitation of the manganese salt complex of lysocellin. The crystalline precipitate was isolated and dried, redissolved in acetone and then recrystallized using the above procedure to yield the crystalline manganese lysocellin salt complex.
The resulting manganese salt complex of lysocellin was amorphous, and had an analysis of 3.73¾
Mn, indicating that two molecules of lysocellin are tied up by one bivalent manganese cation as follows: (C34H59°lO)2Mn·
EXAMPLE IV
The method of Example III was repeated, except that the manganese acetate hydrate was replaced by cupric acetate hydrate /Cu(Ac)2.2^0/. A mixture of 2.6 g of sodium lysocellin, 1.0 g cupric acetate hydrate and 50 ml of acetone was stirred until solution was completed. Stirring was continued, and water (2 col) was added dropwise. The copper salt complex of lysocellin was precipitated, isolated and recrystallized from \2 aqueous acetone. The crystalline copper salt complex of lysocellin had a melting point of 119-122°C and it had 3.68% Cu, indicating there are two molecules of lysocellin tied up by one bivalent copper cation as follows: (C34H59O1q)2Cu.
EXAMPLE V
The in vitro rumen fermentation test described below can be used to accurately predict the improved feed utilization effects of test compounds fed to rum10 inants.
Microorganisms in the rumen of the animal ferment carbohydrates to produce monosaccharides and then degrade the monosaccharides to pyruvate compounds. Pyruvate is then metabolized by microbiological process es to either acetate or proprionate compounds. These compounds may be either acids or other forms of the radicals. Two acetate compounds may be combined still in the rumen to form butyrates.
The animal can utilize butyrate, propionate and acetate with differing degrees of efficiency.
Butyrate is utilized most efficiently and acetate the least efficiently. The relative efficiency of butyrate is negated because it is made from acetate in the rumen.
One of the major inefficiencies in the rumen is in the manufacture of acetate. Since it is made by the degradation of a pyruvate molecule, each molecule of acetate produced is accompanied by a molecule of methane. Most of the methane produced is lost through eructation. Each molecule of butyrate used involves the loss of two molecules of methane with all its associated energy.
Thus, the efficiency of carbohydrate utiliza tion (carbohydrates being the major nutritive portion of animals' feed) can be increased by treatments which encourage the animal to produce propionate rather than acetate from the carbohydrates.
The efficiency of feed use can be effectively monitored by observing the production and concentration of propionate compounds in the rumen. If the animal is making more propionate, it will be found to be using its feed more efficiently. This efficiency is manifested by greater weight gains per feed intake, a reduction in energy losses by methane release, and economic advantages to the animal grower when the animal is sold for consumption.
Procedure
Rumen fluid was removed from a fistulated steer and strained through cheesecloth. An equal amount of pH 7 buffer was added to the strained rumen fluid. After layering occurred, the lower layer was saved and again diluted with an equal amount of butter.
Ten ml portions of the buffered rumen fluid were added to fermentation vessels containing 500 mg of fresh finely ground cattle ration, 1 mg of cellubiose, and amounts of the test compounds that resulted in a 5 ppm concentration.
The vessels were outfitted with one way gas valves and placed in an incubator shaker for 24 hours at 38°C. Fermentation was stopped by the addition of one ml of mercuric chloride.
The liquid was decanted and analyzed for volatile fatty acid by gas chromatography.
Conclusions
Changes in the acetate/propionate ratio caused by six forms of the polyether antibiotic lysocellin were determined by the above in vitro methods.
The acetate/propionate weight ratios given are from means of 10 tests for each compound.
Negative Ex. I Positive LysoControl cellin Ex. II Lysocellin Ex. Ill Lysocellin Control Monensin Na Free Acid Mn
2.04 1.38 1.24 1.26
1.26
Ex. IV Lysocellin
Cu
1.22
All forms of lysocellin tested were more effective than the positive control, monensin, in increasing the relative amount of propionate. From these results it can be concluded that all forms of lysocellin can be expected to improve feed efficiency when fed to ruminants. The fact that all forms of lysocellin performed substantially better than monensin would also indicate a possible effect as a growth promo ter.
EXAMPLE VI
Twenty-five Columbia wether lambs were received and adapted to the basal ration set forth below in Table
1.
54187
Table 1
Composition of the Basal Ration Wether Lamb Test
Interna tiona1
Reference No. Per Cent
Corn, cracked shelled 4-20-931 68.7 Alfalfa-whole corn plant, dehydrated 20.0 Soybean meal (44%) 5-20-637 7.5 Cane molasses 4-04-696 2.0 Limestone 6-02-632 0.8 Trace mineral salt 0.6 Vitamin premixc 0.4 Calculated composition (as fed basis) Crude protein 11.9 Crude fiber 6.8 Calcium 0.48 Phosphorus 0.28 Potassium 0.73 Sulfur 0.27 Digestible energy 3.08 Mcal/kg
aCharles H. Schenk and Sons, Inc., Vincennes, Indiana. Guaranteed analysis: crude protein, min. 12.00%; crude fiber, max. 25.00%; fat, min. 1.50%; calcium, min. 0.75%, Max. 0.87%; and phosphorus, min. 0.20%.
^Composition: NaCl, not 2 99.0%; not/0.35% Zn, 0.34% Fe, 0.200% Mn, 0.033% Cu, 0.077% I, and 0.005% Co.
cProvides per kg of diet: 2750 IU vitamin A; 700 IU vitamin D, and 10 IU vitamin E.·
54187
Animals
Six days after arrival, the lambs were weighed tagged, treated with Tramisol wormer and vaccinated for both contagious ecthyma (soremouth) and Clostridium perfringes type D (overeating disease). Following adaptation, the lambs were reweighed. The lambs were then randomly assigned to five pens (five lambs per pen), providing approximately 1.42 sq. m. per animal. During the following eight-week experimental period, water and feed were available ad libitum.
Compounds Tested
There were four lysocellin materials tested, and a negative control. The test diets and control were each administered to five animals over tlie eight week test period. Each test ration contained the designated lysocellin compound at a level of 30g/ton.
Procedures
The lambs were weighed initially, and biweekly thereafter for the duration of the eight week experiment. The lambs were fasted for eighteen hours prior to weighing. Orts were weighed back at 3:00 P.M. the day prior to weighing the animals.
The effect of the dietary treatments is shown in the following Table 2.
4 16 7
Effects of Addition to Ration of Various Lysocellin Materials in Wether Lambs
Effect Observed Control Sodium Lyso- cellin Lysocellin (Free Acid) Manganese Lyso- cellin Avg. Daily Gain 0.206 0.198 0.198 0.235 (kg/day/head) Gain/Feed 0.148 0.157 0.53 0.171
Of the above treatments, manganese lysocellin was most effective in increasing gain (growth promotion) and feed efficiency. Each of the test compositions showed some improvement in feed efficiency (gain/ feed), and it is expected that when the dosage for each lysocellin material is optimized, all lysocellin materials will show an increase in gain (growth promotion) comparable, or better than, that observed for the manganese lysocellin material.
The manganese or copper lysocellin-containing feed composition is fed to cattle in amounts sufficient to provide from about 5 to 100 ppm of manganese or copper lysocellin in the rumen fluid. Administration of the manganese or copper lysocellin material in this manner serves to promote cattle growth by enhancing the efficiency with which the cattle so treated utilize their feed without suppressing appetite.
Claims (11)
1. An animal feed additive composition capable of increasing the rate of growth of a food-producing animal when supplied in the animal's feed on a regular basis during 5 the animal's normal growth period, and capable of enhancing feed efficiency of the animal, said feed additive composition comprising a lysocellin material selected from lysocellin free acid, and the sodium, manganese copper and magnesium salts of lysocellin. 10
2. The animal feed additive composition of Claim 1, in which the lysocellin material is a metal lysocellin material.
3. The animal feed additive composition of Claim 2, in which the metal lysocellin material is manganese lysocellin.
4. A process for promoting growth and enhancing feed 15 efficiency of food-producing animals which process comprises administering to food-producing animals a growth-promoting and feed efficiency-enhancing amount of lysocellin material selected from lysocellin free acid, and the sodium, manganese, copper and magnesium salts of lysocellin. 20
5. A process in accordance with Claim 4 wherein the lysocellin material is administered parenterally.
6. A process in accordance with Claim 4 wherein the food-producing animals are reminants, and the lysocellin material comprises a metal salt complex which is administered 25 as part of an animal feed composition containing from 1 to 200 grams of lysocellin material per ton of feed.
7. A process in accordance with Claim 6 wherein the animal feed composition is fed to ruminants at a rate sufficient to provide from about 15 to 200 milligrams of 30 the lysocellin material per head per day.
8. A process in accordance with Claim 6 wherein the lysocellin material is administered in amounts sufficient to provide from 5 to 100 ppm of metal lysocellin in the rumen fluid contents
9. A process in accordance with Claim 8 wherein the lysocellin material is manganese lysocellin.
10. A process according to Claim 4 of feeding animals substantially as hereinbefore specifically described in the 5. Examples.
11. An animal feed additive composition as claimed in Claim 1 substantially as hereinbefore specifically described with particular reference to the Examples.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29113481A | 1981-08-07 | 1981-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE821512L IE821512L (en) | 1983-02-07 |
IE54167B1 true IE54167B1 (en) | 1989-07-05 |
Family
ID=23119004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1512/82A IE54167B1 (en) | 1981-08-07 | 1982-06-24 | Process for promoting growth and feed efficiency of food producing mammals |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU559508B2 (en) |
CA (1) | CA1220664A (en) |
GB (1) | GB2107585B (en) |
IE (1) | IE54167B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2951209C (en) * | 2013-06-06 | 2018-09-18 | Rich Technology Solutions Limited | The use of a feed supplement for ruminants |
-
1982
- 1982-06-18 GB GB08217753A patent/GB2107585B/en not_active Expired
- 1982-06-23 AU AU85119/82A patent/AU559508B2/en not_active Ceased
- 1982-06-24 IE IE1512/82A patent/IE54167B1/en unknown
- 1982-06-25 CA CA000406021A patent/CA1220664A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB2107585B (en) | 1985-02-20 |
GB2107585A (en) | 1983-05-05 |
AU8511982A (en) | 1983-02-10 |
IE821512L (en) | 1983-02-07 |
AU559508B2 (en) | 1987-03-12 |
CA1220664A (en) | 1987-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chalupa | Manipulating rumen fermentation | |
US3839557A (en) | Antibiotics monensin and a204 for improving ruminant feed efficiency | |
KR840000750B1 (en) | Poly-ether compounds | |
EP1442664B1 (en) | A method for supplying biovailable methionine to a cow | |
NZ202324A (en) | Cow milk increasing supplement with hydroxybutyric acid derivatives | |
US4336250A (en) | Lactation improvement method | |
US4478935A (en) | Manganese-containing antibiotic agents | |
KR101893735B1 (en) | Pharmaceutical copositions for animal of previntion of intestinal disorder the same method | |
US4761426A (en) | Lysocellin-containing composition and process for promoting growth and feed efficiency of food producing animals | |
US4430328A (en) | Ruminant lactation improvement | |
JP5192108B2 (en) | Composition for inhibiting methanogenesis and composition for feed for ruminants | |
CN1689560A (en) | animal drinking water | |
EP0091649A1 (en) | Method for increasing the efficiency of rumen fermentation of ruminant animals | |
US4933364A (en) | Process for promoting growth and feed efficiency of food producing mammals | |
EP0252380B1 (en) | Antibiotic ll-e19020 alpha and beta | |
US4904689A (en) | Lysocellin-containing feed efficiency-enhancing animal feed | |
US4693992A (en) | Bacitracin-metal-polyether antibiotic complexes | |
CA1220664A (en) | Process for promoting growth and feed efficiency of food producing mammals | |
US4654334A (en) | Manganese-containing antibiotic agents | |
US4892960A (en) | Crystalline lysocellin compositions and method of making | |
US4670260A (en) | Antibiotic for animal feeds | |
US5073369A (en) | Efomycins as performance promoters in animals | |
US4421751A (en) | Bipyridine substituted imidazoylidene, copper complex, and its use in food-producing animals | |
US5081146A (en) | Method and feed supplement for the feeding of ruminants | |
US4567173A (en) | Pyridine, 2,2'-(2-imidazolidinylidene)di-, copper iron and nickel complexes and use in animals |